Skip to content
Search

Latest Stories

GPhC to review revalidation process, seeks pharmacy professionals’ feedback

GPhC to review revalidation process, seeks pharmacy professionals’ feedback

 Grant Thornton appointed to support GPhC in reviewing the revalidation process and framework

The General Pharmaceutical Council (GPhC) is inviting pharmacy technicians and pharmacists who have undergone revalidation since October 2022 to share their experiences by participating in a survey.


Additionally, pharmacy professionals are encouraged to provide feedback on the impact of revalidation and offer comments and suggestions for improving the process.

The Council said: “The purpose of this survey is to ensure that the current revalidation process is effective and meets the needs of professionals and the public.”

To support this review, the GPhC has appointed the consultancy firm Grant Thornton, which will also help in identifying any gaps and determining areas that may require further development.

“The Grant Thornton review will contribute to the development of potential changes to the revalidation framework,” it said.

However, the Council noted that no changes will be introduced before June 2025 and any new proposals will be consulted on fully.

Revalidation with the GPhC is an annual requirement for every pharmacy professional to renew their registration and continue practising in Great Britain.

“It’s one of the ways that we work with you to strengthen public confidence in pharmacy,” the Council said.

The GPhC revalidation framework was introduced five years ago. Since then, the pharmacy sector has evolved rapidly, with new service models.

The Council wants to ensure that the current revalidation process remains effective and continues to meet the needs of both professionals and the public.

This survey is open now and will close on 8 September 2024.

Recently, the GPhC revised the routes to registration for internationally-qualified pharmacists who want to practise in Great Britain, following feedback from stakeholders.

It proposed one single route to registration for all non-European Economic Area (EEA)  or European Free Trade Association (EFTA) internationally-qualified pharmacists, reducing the process from two years to one.

This one-year programme will include both university study and in-practice training.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less